1Zhou Y, Ingelman-Sundberg M, Lauschke VM (2017) Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects. CLIN PHARMACOL THER 102 (4): 688–700 10.1002/cpt.690*10.1002/cpt.690
2Guo C, Xie X, Li J, Huang L, Chen S, Li X, Yi X, Wu Q, Yang G, Zhou H, Liu JP, Chen X (2019) Pharmacogenomics guidelines: Current status and future development. Clin Exp Pharmacol Physiol 46 (8): 689–693 10.1111/1440–1681.13097*10.1111/1440–1681.13097
3D’Attis S, Massari S, Mazzei F, Maio D, Vergallo I, Mauro S, Minelli M, Bozzetti MP (2019) Assessment of CYP2C9, CYP2C19, and CYP2D6 Polymorphisms in Allergic Patients with Chemical Sensitivity. Int Arch Allergy Immunol 179 (3): 173–186 10.1159/000497322*10.1159/000497322
4Moyer AM, Caraballo PJ (2017) The challenges of implementing pharmacogenomic testing in the clinic. Expert Rev Pharmacoecon Outcomes Res 17 (6): 567–577 10.1080/14737167.2017.1385395*10.1080/14737167.2017.1385395
5Caudle KE, Klein TE, Hoffman JM, Muller DJ, Whirl-Carrillo M, Gong L, McDonagh EM, Sangkuhl K, Thorn CF, Schwab M, Agundez JA, Freimuth RR, Huser V, Lee MT, Iwuchukwu OF, Crews KR, Scott SA, Wadelius M, Swen JJ, Tyndale RF, Stein CM, Roden D, Relling MV, Williams MS, Johnson SG (2014) Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. CURR DRUG METAB 15 (2): 209–217
6Denny JC, Van Driest SL, Wei WQ, Roden DM (2018) The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development. CLIN PHARMACOL THER 103 (3): 409–418 10.1002/cpt.951*10.1002/cpt.951
7Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y (2016) Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack. JAMA 316 (1): 70–78 10.1001/jama.2016.8662*10.1001/jama.2016.8662
8Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodriguez TJ, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V, Eby CS (2017) Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA 318 (12): 1115–1124 10.1001/jama.2017.11469*10.1001/jama.2017.11469
9Syn NL, Wong AL, Lee SC, Teoh HL, Yip J, Seet RC, Yeo WT, Kristanto W, Bee PC, Poon LM, Marban P, Wu TS, Winther MD, Brunham LR, Soong R, Tai BC, Goh BC (2018) Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial. BMC MED 16 (1): 104 10.1186/s12916–018–1093–8*10.1186/s12916–018–1093–8
10Caudle KE, Dunnenberger HM, Freimuth RR, Peterson JF, Burlison JD, Whirl-Carrillo M, Scott SA, Rehm HL, Williams MS, Klein TE, Relling MV, Hoffman JM (2017) Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC). GENET MED 19 (2): 215–223 10.1038/gim.2016.87*10.1038/gim.2016.87
11Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS (2017) Prediction of CYP2D6 phenotype from genotype across world populations. GENET MED 19 (1): 69–76 10.1038/gim.2016.80*10.1038/gim.2016.80